tirzepatide phase 3 study results A 3-year of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Tirzepatide after intensive lifestyle intervention
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6



01774-X/asset/3608bfb3-6329-4132-95b7-cc3434437493/main.assets/gr2_lrg.jpg)
01324-6/asset/51ce73b3-a19e-4648-ac19-5ec7099db908/main.assets/gr3_lrg.jpg)






















